Abstract
Mutation of the p53 protein may represent the commonest genetic event in human malignancy. Abnormal p53 expression has been reported in a variety of carcinomas, sarcomas and lymphoid neoplasms; however there is little information in relation to Hodgkin's disease. The expression of the nuclear phosphoprotein was investigated in paraffin-embedded biopsies from fifty patients with Hodgkin's disease using a polyclonal antibody, CM-1 and in snap-frozen material with monoclonal antibodies, PAb 1801 and PAb 240. Specifically, immunoreactivity was localised to the Reed-Sternberg cells or mononuclear variants in both nodular sclerosing (86% cases) and mixed cellularity (57% cases) subtypes of Hodgkin's disease. However, no positive staining was found in our cases of nodular lymphocyte predominant type Hodgkin's disease. Serial biopsies following recurrence of disease demonstrated consistent results. It is suggested that overexpression of p53, probably mutant, may have a role in the tumorigenesis of Hodgkin's disease.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gupta, R., Norton, A., Thompson, I. et al. p53 expression in Reed-Sternberg cells of Hodgkin's disease. Br J Cancer 66, 649–652 (1992). https://doi.org/10.1038/bjc.1992.331
Issue Date:
DOI: https://doi.org/10.1038/bjc.1992.331
- Springer Nature Limited
This article is cited by
-
Expression and prognostic significance of cox-2 and p-53 in hodgkin lymphomas: a retrospective study
Diagnostic Pathology (2010)